• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性黄斑变性中的双侧黄斑玻璃膜疣。预后及危险因素。

Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors.

作者信息

Holz F G, Wolfensberger T J, Piguet B, Gross-Jendroska M, Wells J A, Minassian D C, Chisholm I H, Bird A C

机构信息

Department of Clinical and Preventive Ophthalmology, Moorfields Eye Hospital, London, United Kingdom.

出版信息

Ophthalmology. 1994 Sep;101(9):1522-8. doi: 10.1016/s0161-6420(94)31139-0.

DOI:10.1016/s0161-6420(94)31139-0
PMID:8090455
Abstract

BACKGROUND

In patients with unilateral visual loss related to age-related macular disease, the risk of visual loss in the second eye is documented as being between 7% and 10% per year. The risk is uncertain in those with good vision with each eye and bilateral macular drusen.

METHODS

In a prospective study, 126 patients with bilateral drusen were reviewed annually for up to 3 years. Serial fundus photographs and fluorescein angiograms were analyzed independently by two readers in a masked fashion using a standardized grading scheme, including size, number, density, and fluorescence angiographic behavior of drusen.

RESULTS

New lesions occurred in one or both eyes of 17 (13.5%) of the 126 patients. The cumulative incidence of exudative or nonexudative lesions was 8.55% at 1 year, at 2 years 16.37%, and 23.52% at 3 years for patients older than 65 years of age. Significant risk factors included the degree of confluence of drusen within 1600 microns of the center of the fovea (P = 0.023), focal hyperpigmentation (P = 0.004), slow choroidal filling (P = 0.023), and focal extrafoveal areas of atrophy of the retinal pigment epithelium (P = 0.042).

CONCLUSIONS

The results give an estimate for the incidence of complicating lesions in patients with bilateral drusen and identify those features indicating higher than average risk of visual loss.

摘要

背景

在与年龄相关性黄斑病变相关的单侧视力丧失患者中,有记录显示,另一只眼睛每年的视力丧失风险在7%至10%之间。对于双眼视力良好且有双侧黄斑玻璃膜疣的患者,该风险尚不确定。

方法

在一项前瞻性研究中,对126例双侧玻璃膜疣患者进行了为期3年的年度复查。两名阅片者采用标准化分级方案,以盲法独立分析系列眼底照片和荧光素血管造影,包括玻璃膜疣的大小、数量、密度和荧光血管造影表现。

结果

126例患者中有17例(13.5%)一只或两只眼睛出现了新病变。65岁以上患者渗出性或非渗出性病变的累积发生率在1年时为8.55%,2年时为16.37%,3年时为23.52%。显著的风险因素包括黄斑中心凹1600微米范围内玻璃膜疣的融合程度(P = 0.023)、局灶性色素沉着(P = 0.004)、脉络膜充盈缓慢(P = 0.023)以及视网膜色素上皮的局灶性黄斑外萎缩区域(P = 0.042)。

结论

该结果给出了双侧玻璃膜疣患者并发病变的发生率估计,并确定了那些表明视力丧失风险高于平均水平的特征。

相似文献

1
Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors.年龄相关性黄斑变性中的双侧黄斑玻璃膜疣。预后及危险因素。
Ophthalmology. 1994 Sep;101(9):1522-8. doi: 10.1016/s0161-6420(94)31139-0.
2
[Macular drusen. Changes in the retinal pigment epithelium and angiographic characteristics as prognostic markers].[黄斑玻璃膜疣。视网膜色素上皮的变化及血管造影特征作为预后标志物]
Ophthalmologe. 1994 Dec;91(6):735-40.
3
Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration.阈下红外(810纳米)二极管激光黄斑格栅光凝治疗非渗出性年龄相关性黄斑变性后玻璃膜疣减少的预测因素
Am J Ophthalmol. 2002 Oct;134(4):577-85. doi: 10.1016/s0002-9394(02)01691-4.
4
Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group.对患有大玻璃膜疣的眼睛进行激光治疗。一项初步随机临床试验的短期效果。脉络膜新生血管预防试验研究组。
Ophthalmology. 1998 Jan;105(1):11-23.
5
Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.红外(810纳米)二极管激光黄斑格栅光凝术在非渗出性年龄相关性黄斑变性预防性治疗中的疗效:一项随机试验性研究的两年结果
Ophthalmology. 1999 Nov;106(11):2082-90. doi: 10.1016/S0161-6420(99)90487-6.
6
Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.年龄相关性黄斑变性预防试验并发症中脉络膜新生血管形成和地图样萎缩的危险因素。
Ophthalmology. 2008 Sep;115(9):1474-9, 1479.e1-6. doi: 10.1016/j.ophtha.2008.03.008. Epub 2008 May 27.
7
Long-term drusen study.长期玻璃膜疣研究。
Retina. 1999;19(6):513-9. doi: 10.1097/00006982-199911000-00006.
8
Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group.年龄相关性黄斑变性和单侧黄斑中心凹外脉络膜新生血管患者对侧眼的五年随访。黄斑光凝研究组
Arch Ophthalmol. 1993 Sep;111(9):1189-99. doi: 10.1001/archopht.1993.01090090041018.
9
Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration.年龄相关性黄斑变性中玻璃膜疣与视网膜色素上皮异常的临床病理相关性
Retina. 1994;14(2):130-42.
10
Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study.玻璃膜疣及视网膜色素上皮异常的五年发病率和消失情况。沃特曼研究。
Arch Ophthalmol. 1995 Mar;113(3):301-8. doi: 10.1001/archopht.1995.01100030055022.

引用本文的文献

1
Five-year Outcome of Aflibercept Administration with "Treat and Extend" for Neovascular Age-Related Macular Degeneration.阿柏西普采用“治疗并延长”方案治疗新生血管性年龄相关性黄斑变性的五年疗效
Clin Ophthalmol. 2025 Mar 12;19:835-845. doi: 10.2147/OPTH.S501953. eCollection 2025.
2
The Need for Artificial Intelligence Based Risk Factor Analysis for Age-Related Macular Degeneration: A Review.基于人工智能的年龄相关性黄斑变性危险因素分析的必要性:综述
Diagnostics (Basel). 2022 Dec 30;13(1):130. doi: 10.3390/diagnostics13010130.
3
Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization.
用于治疗黄斑下脉络膜新生血管的瑞戈非尼缓释微球
Pharmaceutics. 2021 Sep 24;13(10):1548. doi: 10.3390/pharmaceutics13101548.
4
Foveal Avascular Zone and Choroidal Thickness Are Decreased in Subjects with Hard Drusen and without High Genetic Risk of Developing Alzheimer's Disease.在患有硬性玻璃膜疣且无阿尔茨海默病高遗传风险的受试者中,黄斑无血管区和脉络膜厚度降低。
Biomedicines. 2021 Jun 2;9(6):638. doi: 10.3390/biomedicines9060638.
5
Portable Diagnostic System for Age-Related Macular Degeneration Screening Using Visual Evoked Potentials.使用视觉诱发电位的年龄相关性黄斑变性筛查便携式诊断系统
Eye Brain. 2021 Apr 29;13:111-127. doi: 10.2147/EB.S295745. eCollection 2021.
6
Five-year treatment outcomes following intravitreal ranibizumab injections for neovascular age-related macular degeneration in Japanese patients.日本患者玻璃体内注射雷珠单抗治疗新生血管性年龄相关性黄斑变性的五年治疗结果。
Graefes Arch Clin Exp Ophthalmol. 2019 Jul;257(7):1411-1418. doi: 10.1007/s00417-019-04361-8. Epub 2019 May 22.
7
[Development and validation of novel clinical endpoints in intermediate age-related macular degeneration in MACUSTAR].[MACUSTAR研究中年龄相关性黄斑变性中期新型临床终点的开发与验证]
Ophthalmologe. 2019 Dec;116(12):1186-1193. doi: 10.1007/s00347-019-0907-1.
8
Six-Year Incidence and Risk Factors of Age-Related Macular Degeneration in Singaporean Indians: The Singapore Indian Eye Study.新加坡印度人年龄相关性黄斑变性的六年发生率及相关因素:新加坡印度人眼研究。
Sci Rep. 2018 Jun 11;8(1):8869. doi: 10.1038/s41598-018-27202-w.
9
Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.激光治疗玻璃膜疣以预防进展为晚期年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2015 Oct 23;2015(10):CD006537. doi: 10.1002/14651858.CD006537.pub3.
10
Disappearance of soft drusen and subsequent development of choroidal neovascularization following macular hole surgery: a case report.黄斑裂孔手术后软性玻璃膜疣消失及随后脉络膜新生血管形成:一例报告
BMC Ophthalmol. 2015 Apr 28;15:43. doi: 10.1186/s12886-015-0029-8.